ARPO insider transactions
Aerpio Pharmaceuticals, Inc. (ARPO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ARPO
- SEC Form 4 filed by Delaney Brendan4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 3 filed by new insider Delaney Brendan3 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 4 filed by Desai Neil4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 4 filed by Reeve Emma4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 3 filed by new insider Reeve Emma3 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 4 filed by Hehenberger Karin M.4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 4 filed by Maroun Richard E4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 3 filed by new insider Hehenberger Karin M.3 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 3 filed by new insider Thibault Lance E3 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 3 filed by new insider Maroun Richard E3 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 3: New insider Desai Neil claimed ownership of 2,558,791 units of Common Stock3 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 4: Dalal Anupam bought $19,999,990 worth of Common Stock (1,529,402 units at $13.08) (Amendment)4/A - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 4: Castelein Caley bought $3,399,994 worth of Common Stock (259,998 units at $13.08)4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 4: Dalal Anupam bought $19,999,990 worth of Common Stock (1,529,402 units at $13.08)4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 4: Aghazadeh Behzad was granted 1,911,752 units of Common Stock4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 3: New insider Aghazadeh Behzad claimed ownership of 300,000 units of Common Stock3 - Aadi Bioscience, Inc. (0001422142) (Issuer)
- SEC Form 4: Dalal Anupam was granted 7,400 units of Common Stock, increasing direct ownership by 77% to 16,959 units4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4 filed by Aerpio Pharmaceuticals, Inc.4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4: Prelack Steven was granted 12,334 units of Common Stock, increasing direct ownership by 102% to 24,485 units4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4: Castelein Caley was granted 7,811 units of Common Stock, increasing direct ownership by 3% to 295,414 units4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4: Cohen Cheryl was granted 8,140 units of Common Stock, increasing direct ownership by 101% to 16,160 units4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4 filed by Cohen Cheryl4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4: Caley Castelein was granted 7,696 units of Common Stock, increasing direct ownership by 3% to 287,603 units4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4: Steven Prelack was granted 12,151 units of Common Stock4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4: Pravin Dugel was granted 6,237 units of Common Stock4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4: Anupam Dalal was granted 7,290 units of Common Stock, increasing direct ownership by 321% to 9,559 units4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4: Cheryl Cohen was granted 8,020 units of Common Stock4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4 filed by Pravin Dugel4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4 filed by Cheryl Cohen4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4 filed by Anupam Dalal4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
- SEC Form 4 filed by Caley Castelein4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)